DISCOVERY LABORATORIES INC DEF 14A 6-9-2015

Company

WINDTREE THERAPEUTICS INC /DE/

Filed

April 29, 2015

Period of Report

June 9, 2015

Accession Number

0001140361-15-016725

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →